{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:27:23Z","timestamp":1759624043594,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.ejogrb.2003.12.024","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T16:59:33Z","timestamp":1093625973000},"page":"211-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion"],"prefix":"10.1016","volume":"116","author":[{"given":"Ai H.","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue J.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dun Zh.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen L.","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi R.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2003.12.024_BIB1","doi-asserted-by":"crossref","unstructured":"Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998;13:2962\u20135.","DOI":"10.1093\/humrep\/13.10.2962"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB3","doi-asserted-by":"crossref","unstructured":"Schaff EA, Eisinger SH, Stadalius LS, Frauks P, Gore BZ, Poppema S. Low dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999;59:1\u20136.","DOI":"10.1016\/S0010-7824(98)00150-4"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB4","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.284.15.1948","article-title":"Vaginal misoprostol administrated 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial","volume":"284","author":"Schaff","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB5","doi-asserted-by":"crossref","unstructured":"UK Multicentre Trial. The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. Br J Obstet Gynaecol 1990;97:480\u20136.","DOI":"10.1111\/j.1471-0528.1990.tb02516.x"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB6","doi-asserted-by":"crossref","unstructured":"World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993;307:532\u20137.","DOI":"10.1136\/bmj.307.6903.532"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB7","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/oxfordjournals.humrep.a138287","article-title":"The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol","volume":"8","author":"Mckinley","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0010-7824(00)00187-6","article-title":"Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost","volume":"62","author":"Bartley","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB9","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/0140-6736(91)92102-8","article-title":"Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone","volume":"338","author":"Norman","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB10","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/HUMREP\/10.6.1521","article-title":"Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion","volume":"10","author":"Baird","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM199504133321502","article-title":"Induction of abortion with mifepristone (Ru486) and oral vaginal misoprostol","volume":"332","author":"El-Rafaey","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archfami.7.4.360","article-title":"Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol","volume":"7","author":"Winikeff","year":"1998","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2307\/3097714","article-title":"Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden","volume":"34","author":"Jones","year":"2002","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB14","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/humrep\/17.6.1477","article-title":"A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy","volume":"17","author":"Jain","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB15","first-page":"434","article-title":"Mifepristone 100 mg in abortion regimens","volume":"98","author":"Creinin","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB16","first-page":"8","article-title":"Phamacokinetic study on Ru486 and its metabolites after oral administration of various doses in pregnant and non-pregnant women","volume":"12","author":"Shi","year":"1992","journal-title":"Reprod Contracept"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB17","first-page":"17","article-title":"Pharmacokinetics of Ru486 and its active metabolites in humans","volume":"64","author":"Foldesi","year":"1994","journal-title":"Acta Pharm Hung"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0301-2115(01)00522-X","article-title":"Mifepristone: bioavailability, pharmacokinetics and use-effectiveness","volume":"101","author":"Sarkar","year":"2002","journal-title":"Eur. J. Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/humrep\/14.3.722","article-title":"A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol","volume":"14","author":"Tang","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB20","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/humrep\/17.11.2865","article-title":"A prospective randomized study on the measured blood in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristone","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2003.12.024_BIB21","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1093\/humrep\/17.12.3079","article-title":"Early pregnancy termination with vaginal misoprostol before and after 42 days gestation","volume":"17","author":"Zikopoulos","year":"2002","journal-title":"Hum Reprod"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:11:58Z","timestamp":1759554718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211504000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0301211504000302"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2003.12.024","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2003.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}